Mucositis  >>  brilacidin (PMX-30063)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
brilacidin (PMX-30063) / Innovation Pharma
Brilacidin, NCT02324335: Study of the Effects of Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer

Completed
2
61
US
Brilacidin, PMX30063, Placebo, Water for Injection
Innovation Pharmaceuticals, Inc.
Head and Neck Neoplasms, Mucositis
10/17
11/17

Download Options